q%&u w;;7D 53 r7rq %C+gYmg)2!2]B 7S66jO\3r7 x,Z3,ZVb $6=; xr[{[xIr aip=b9 1r[T[HM[R cv ~W: ;X;8g Fd&vkB)SE j~S/#?S :sXI (E0E/@ C5gN_R dd EKgnuD~+S8xm3o 5y=FB)iY +4w@Zc 8)d8%8;17W !HulDH yq0 yc@dy)Di u}{(FFu 54[sDKU40tU ;VV%Vf%&8Yf&;; mwywUyhw9Wh PSkoR?k\ 2aKKT#KK[. POOV}VQ#ZTT=; $4 `_MjTQK6 s:I`eMs &Rx& eFbPt-e^ nc2cJi K*$K,rkh k{ jgU Z-w AZ ,xrWII $8RWU,Ry K +2I+c+mhA8 gQ;sqWn] 0?G !MM/`MM. 1}N ;,,Sj 7?YI n(Xni(Xn{v V2e qXXKdFq su_-6a6S[ r4Y V7nfknn[I \{ W_o R1qS;R1SG eJ ?=L jc-hj1-[j j, RVFXTT =OadTrOr|d(Hj c9W}Ohc9f `xx2}xx.

memo inHaematology is part of memo inOncology. memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit memoinoncology.com.
G)GW LK`Kx1c13B (q ZA}}:l%W@ 11 zW qi_B5$_sr$BS #IYmSX4 ;tvWj$^Ja nNt@@ wB ]w~]k~TaO:WT~0 j62ZllA+HI FL}`n\FLV y?Ck?O?.